MARVELD3 and pancreatic neoplasm: MarvelD3 was transcriptionally downregulated during mesenchymal transition in pancreatic cancer cells [69], whereas its expression inhibits EMT, along with NF-κB pathway inactivation, a main regulator of EMT and cell metastasis [70].